RCMT Stock Analysis: RCM Technologies | NASDAQ
Conglomerates | NASDAQ, USA | Market Cap: 289m USD | 12M Return: 52.5% | US7493604000 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.10M
EPS Trend: 71.5%
Qual. Beats: 1
Rev. Trend: 97.9%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
RCM Technologies, Inc. (NASDAQ: RCMT) is a U.S.-based provider of business and technology solutions operating across three segments: Engineering, Specialty Health Care, and Life Sciences, Data and Solutions (LS&D). The company delivers a mix of engineering services (including project management, design, power delivery, and quality assurance), healthcare and allied staffing (covering nursing, correctional healthcare, school staffing, and telepractice), and enterprise IT and data solutions. It serves a diversified client base spanning aerospace/defense, education, energy, financial services, healthcare, life sciences, manufacturing, public sector, and technology, with operations in the United States, Canada, Puerto Rico, Europe, and the Philippines. Founded in 1971 and headquartered in Pennsauken, New Jersey, RCMT is classified within the Industrials sector under Research & Consulting Services, a grouping that encompasses staffing firms, engineering consultancies, and IT services providers whose revenue tends to track project-based demand and labor market conditions.
- Energy grid modernization fuels engineering segment revenue growth
- Healthcare staffing margins pressured by rising clinician wage costs
- Aerospace and defense contract awards drive backlog expansion
| Net Income: 17.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 16.74 > 1.0 |
| NWC/Revenue: 14.44% < 20% (prev 15.41%; Δ -0.97% < -1%) |
| CFO/TA 0.18 > 3% & CFO 23.7m > Net Income 17.1m |
| Net Debt (23.8m) to EBITDA (28.0m): 0.85 < 3 |
| Current Ratio: 1.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (7.61m) vs 12m ago 1.02% < -2% |
| Gross Margin: 26.59% > 18% (prev 27.62%; Δ -1.03% > 0.5%) |
| Asset Turnover: 247.5% > 50% (prev 221.2%; Δ 26.30% > 0%) |
| Interest Coverage Ratio: 9.42 > 6 (EBIT TTM 25.8m / Interest Expense TTM 2.74m) |
| A: 0.36 (Total Current Assets 100.4m - Total Current Liabilities 52.2m) / Total Assets 134.0m |
| B: 0.14 (Retained Earnings 19.1m / Total Assets 134.0m) |
| C: 0.19 (EBIT TTM 25.8m / Avg Total Assets 134.8m) |
| D: 0.57 (Book Value of Equity 48.8m / Total Liabilities 85.2m) |
| Altman-Z'' = 4.71 = AA |
| DSRI: 0.87 (Receivables 88.1m/91.2m, Revenue 333.6m/299.9m) |
| GMI: 1.04 (GM 27.62% / 26.59%) |
| AQI: 1.01 (AQ_t 0.17 / AQ_t-1 0.17) |
| SGI: 1.11 (Revenue 333.6m / 299.9m) |
| TATA: -0.05 (NI 17.1m - CFO 23.7m) / TA 134.0m) |
| Beneish M = -3.02 (Cap -4..+1) = AA |
As of September 27, 2026, the stock is trading at USD 40.47 with a total of 37,657 shares traded. Over the past week, the price has changed by +2.74%, over one month by -3.64%, over three months by +47.32% and over the past year by +52.54%.
Current recommended Stop Loss: 38.00 (which is 6.1% or 1.7 ATR below the current price).
RCM Technologies has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy RCMT.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 45 | 11.2% |
P/E Trailing = 17.1392
P/E Forward = 12.8041
P/S = 0.8658
P/B = 5.7425
P/EG = 1.36
Revenue TTM = 333.6m USD
EBIT TTM = 25.8m USD
EBITDA TTM = 28.0m USD
Long Term Debt = 23.4m USD (from longTermDebt, last quarter)
Short Term Debt = 1.14m USD (from shortTermDebt, last quarter)
Debt = 30.4m USD (corrected: LT Debt 23.4m + ST Debt 1.14m) + Leases 5.84m
Net Debt = 23.8m USD (calculated: Debt 30.4m - CCE 6.58m)
Enterprise Value = 312.6m USD (288.8m + Debt 30.4m - CCE 6.58m)
Interest Coverage Ratio = 9.42 (Ebit TTM 25.8m / Interest Expense TTM 2.74m)
EV/FCF = 13.70x (Enterprise Value 312.6m / FCF TTM 22.8m)
FCF Yield = 7.30% (FCF TTM 22.8m / Enterprise Value 312.6m)
FCF Margin = 6.84% (FCF TTM 22.8m / Revenue TTM 333.6m)
Net Margin = 5.13% (Net Income TTM 17.1m / Revenue TTM 333.6m)
Gross Margin = 26.59% ((Revenue TTM 333.6m - Cost of Revenue TTM 244.9m) / Revenue TTM)
Gross Margin QoQ = 25.67% (prev 25.85%)
Tobins Q-Ratio = 2.33 (Enterprise Value 312.6m / Total Assets 134.0m)
Interest Expense / Debt = 9.02% (Interest Expense 2.74m / Debt 30.4m)
Taxrate = 25.97% (6.00m / 23.1m)
NOPAT = 19.1m (EBIT 25.8m * (1 - 25.97%))
Current Ratio = 1.92 (Total Current Assets 100.4m / Total Current Liabilities 52.2m)
Debt / Equity = 0.62 (Debt 30.4m / totalStockholderEquity, last quarter 48.8m)
Debt / EBITDA = 0.85 (Net Debt 23.8m / EBITDA 28.0m)
Debt / FCF = 1.04 (Net Debt 23.8m / FCF TTM 22.8m)
Total Stockholder Equity = 45.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.69% (Net Income 17.1m / Total Assets 134.0m)
RoE = 37.92% (Net Income TTM 17.1m / Total Stockholder Equity 45.1m)
RoCE = 37.67% (EBIT 25.8m / Capital Employed (Equity 45.1m + L.T.Debt 23.4m))
RoIC = 25.01% (NOPAT 19.1m / Invested Capital 76.4m)
WACC = 9.65% (E(288.8m)/V(319.2m) * Re(9.96%) + D(30.4m)/V(319.2m) * Rd(9.02%) * (1-Tc(0.26)))
Discount Rate = 9.96% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -84.05 | Cagr: -3.08%
[DCF] Terminal Value 73.89% ; FCFF base≈13.9m ; Y1≈15.9m ; Y5≈23.4m
[DCF] Fair Price = 36.91 (EV 286.2m - Net Debt 23.8m = Equity 262.5m / Shares 7.11m; r=9.65% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 71.50 | EPS CAGR: 7.99% | SUE: 1.31 | # QB: 1
Revenue Correlation: 97.92 | Revenue CAGR: 9.65% | SUE: 2.30 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.55 | Chg30d=+19.57% | Revisions=+25% | Analysts=2
EPS current Year (2026-12-31): EPS=2.96 | Chg30d=+7.85% | Revisions=+25% | GrowthEPS=+18.2% | GrowthRev=+11.5%
EPS next Year (2027-12-31): EPS=3.27 | Chg30d=+3.00% | Revisions=+25% | GrowthEPS=+10.5% | GrowthRev=+10.1%
[Analyst] Revisions Ratio: +50% (up=3, down=0)